Offer - Urjas Oil for just ₹ 1 X
Triolmighty 40 Tablet, a prescription drug, is manufactured in various forms such as Tablet. The alternative uses of Triolmighty 40 Tablet have also been explained below.
The optimal dosage of Triolmighty 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Triolmighty 40 Tablet include Upper respiratory tract infection. While these are the most often observed Triolmighty 40 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Triolmighty 40 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Triolmighty 40 Tablet has a Safe effect for pregnant women and Safe effect on lactating mothers. It is important to know if Triolmighty 40 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Triolmighty 40 Tablet related warnings section.
Triolmighty 40 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. The section on Triolmighty 40 Tablet contraindications lists all such conditions.
Besides this, Triolmighty 40 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Triolmighty 40 Tablet is considered not safe while driving, and is not addictive.
Triolmighty 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Triolmighty 40 Tablet safe for pregnant women?
Pregnant women can take Triolmighty without worrying about any side effects.
Is the use of Triolmighty 40 Tablet safe during breastfeeding?
Breastfeeding women can safely use Triolmighty.
What is the effect of Triolmighty 40 Tablet on the Kidneys?
Triolmighty has very mild side effects on the kidneys.
What is the effect of Triolmighty 40 Tablet on the Liver?
Triolmighty may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Triolmighty 40 Tablet on the Heart?
Triolmighty has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Triolmighty 40 Tablet unless your doctor advises you to do so -
Is this Triolmighty 40 Tablet habit forming or addictive?
No, there is no any evidence that Triolmighty 40 Tablet is addictive.
Interaction between Food and Triolmighty 40 Tablet
When consumed with certain foods, Triolmighty 40 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Triolmighty 40 Tablet
Taking alcohol with Triolmighty 40 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448